ERASCA
Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery programs for undisclosed targets that are biological drivers of cancer and are pursuing additional opportunities for pipeline expansion through academic and biopharmaceutical collaborations, providing patients with new potential solutions to not just treat but cure cancer. It was founded in 2018 and headquartered in San Diego, California.
ERASCA
Social Links:
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.erasca.com
Total Employee:
11+
Status:
Active
Contact:
(858) 465-6511
Email Addresses:
[email protected]
Total Funding:
300 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Partner Fund Management
Partner Fund Management investment in Series B - Erasca
OrbiMed
OrbiMed investment in Series B - Erasca
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Erasca
City Hill Ventures
City Hill Ventures investment in Series B - Erasca
EDBI
EDBI investment in Series B - Erasca
Invus
Invus investment in Series B - Erasca
Terra Magnum Capital Partners (""""TMCP"""")""
Terra Magnum Capital Partners (""""TMCP"""")"" investment in Series B - Erasca
Colt Ventures
Colt Ventures investment in Series B - Erasca
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Erasca
LifeSci Venture Partners
LifeSci Venture Partners investment in Series B - Erasca
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-18 | Erasca Strengthens Leadership Team with Two Key Executive Appointments |
Official Site Inspections
http://www.erasca.com Semrush global rank: 4.01 M Semrush visits lastest month: 3.09 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Erasca"
Erasca - Crunchbase Company Profile & Funding
Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery …See details»
About - Erasca
At erasca, our name is our mission:to erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for RAS- and MAPK pathway-driven cancers. …See details»
People - Erasca
Prior to Erasca, she was one of the first 20 employees at Myovant Sciences, serving as Vice President of Pharmaceutical Operations and Development, where she built the CMC …See details»
Investors – Erasca
Corporate overview. Erasca is a clinical-stage, precision oncology company with a bold mission—to erase cancer. We are focused on the discovery, development and …See details»
Erasca, Inc. - LinkedIn
Erasca, Inc. Biotechnology Research San Diego, California 6,764 followers Our mission at Erasca is embedded in our name: To erase cancer.See details»
Erasca, Inc. Overview | SignalHire Company Profile
Erasca, Inc. is a public company that has been in the industry for 6 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the Chairman & CEO …See details»
ERASCA, INC. Company Profile | San Diego, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ERASCA, INC. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Erasca - The Org
Erasca is dedicated to advancing exceptional scientific approaches to erase cancer. Industries. Biotechnology, EducationSee details»
Erasca - Contacts, Employees, Board Members, Advisors & Alumni
Erasca is a developer of oncology drugs intended to provide precision oncology options. New. Resources. Advanced Search ... Experience the new Crunchbase, powered by AI . Experience …See details»
Erasca, Inc. - AnnualReports.com
Erasca, Inc. Most Recent Annual Report. MOST RECENT 2023 Annual Report and Form 10K. View PDF View Form 10K (HTML) Older/Archived Annual Reports. 2022 Annual Report View …See details»
Erasca Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Erasca is a clinical-stage precision oncology company that discovers, develops, and commercializes therapies for cancer patients. It offers upstream and downstream mitogen …See details»
Careers - Erasca
Are you ready to become a part of our exceptional, mission-driven organization? Core Value. Key Ingredient. Committed to erasing cancer in patients. Mission-Driven: We are ... Jonathan is …See details»
Erasca Presents New Preclinical Data Reinforcing - GlobeNewswire
3 days ago Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting. April 29, 2025 16:05 ET | Source: …See details»
Erasca, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Mar 8, 2025 Erasca also announced progress on its pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 programs, confirming best-in-class potential and preparing for …See details»
Erasca Mission, Values, Culture & Jobs - Teal_HQ
Erasca was founded in 2018 and is headquartered in San Diego, California. Mission. Erasca's core mission is centered around eradicating cancer by revolutionizing the way it is detected, …See details»
Erasca Presents New Preclinical Data Reinforcing Best-in-Class ...
3 days ago Erasca Presents New Preclinical Data Reinforcing Best-in-Class Potential of RAS-Targeting Franchise at the 2025 AACR Annual Meeting Erasca, Inc. Tue, Apr 29, 2025, 4:05 …See details»
Erasca, Inc. Reports Promising Preclinical Data on ERAS-0015
3 days ago Erasca, Inc. presented new preclinical data at the American Association for Cancer Research Annual Meeting, showcasing their RAS-targeting compounds, ERAS-0015 and …See details»
Erasca Expands Leadership Team with Key Appointments
May 27, 2021 Prior to Erasca, she was one of the first 20 employees at Myovant Sciences, serving as vice president of pharmaceutical operations and development, where she built the …See details»
Erasca Presents New Preclinical Data Reinforcing Best-in-Class ...
4 days ago Erasca cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. The forward-looking …See details»
Erasca - workinbiotech.com
Erasca is a precision oncology company with a clear mission: to erase cancer. Cancer is a genetic disease driven by mutations in different cellular pathways that promote uncontrolled cell …See details»